J2785 HCPCS code: Injection, regadenoson, 0.1 mg
J2785 is the HCPCS Level II code for injection, regadenoson, 0.1 mg. In 2024 Medicare paid an average of $5.33 per service for J2785 across 2,260,631 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 4 per day on outpatient hospital claims. Medicare volume rose 4% from 2022 to 2024 (2,183,212 to 2,260,631 services). In 2024, about 9,511 clinicians billed Medicare for J2785 for 567,854 beneficiaries; California, Florida, Texas accounted for 41% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2009-01-01 |
| Last action effective | 2014-01-01 |
Who bills J2785 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 9,511 |
| Medicare beneficiaries | 567,854 |
| States with claims | 53 |
| Share of services in top 3 states (California, Florida, Texas) | 41% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2785, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 2,183,212 | 547,061 | $60.12 | $47.80 |
| 2023 | 2,228,526 | 558,009 | $53.37 | $42.36 |
| 2024 | 2,260,631 | 567,854 | $6.77 | $5.33 |
States with the most J2785 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 328,447 | $5.41 |
| Florida | 307,688 | $5.40 |
| Texas | 284,931 | $5.27 |
| New York | 162,390 | $5.34 |
| Arizona | 115,564 | $5.48 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 4 | Prescribing Information |
| practitioner claims | 4 | Prescribing Information |
Medicare policy articles for this code
- A56494: Billing and Coding: Cardiovascular Nuclear Medicine (CGS Administrators, LLC (MAC - Part A, MAC - Part B))
- A56781: Billing and Coding: Transthoracic Echocardiography (TTE) (Wellpoint Federal (MAC - Part A, MAC - Part B))
- A57306: Billing and Coding: Transthoracic Echocardiography (TTE) (CGS Administrators, LLC (MAC - Part A, MAC - Part B))
Covered diagnoses (1,728 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| I20.0 | Unstable angina | 3 |
| I20.1 | Angina pectoris with documented spasm | 3 |
| I20.81 | Angina pectoris with coronary microvascular dysfunction | 3 |
| I20.89 | Other forms of angina pectoris | 3 |
| I21.01 | ST elevation (STEMI) myocardial infarction involving left main coronary artery | 3 |
| I21.02 | ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery | 3 |
| I21.09 | ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall | 3 |
| I21.11 | ST elevation (STEMI) myocardial infarction involving right coronary artery | 3 |
| I21.19 | ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall | 3 |
| I21.21 | ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery | 3 |
Showing 10 of 1,728. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J2785
- 2009-01-01: J2785 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2785?
J2785 is the HCPCS Level II code for injection, regadenoson, 0.1 mg. Short descriptor: "Regadenoson injection".
How much does Medicare pay for J2785?
In 2024, the average Medicare payment was $5.33 per service (average allowed $6.77).
Does Medicare cover J2785?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for J2785?
Medicare policy articles that cite J2785 list 1,728 covered ICD-10-CM diagnosis codes across 3 articles. The most cited include I20.0 (Unstable angina), I20.1 (Angina pectoris with documented spasm), I20.81 (Angina pectoris with coronary microvascular dysfunction). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J2785 can be billed per day?
4 on outpatient hospital claims; 4 on practitioner claims (NCCI medically unlikely edits).
Related J27 codes
- J2700 — Injection, oxacillin sodium, up to 250 mg
- J2704 — Injection, propofol, 10 mg
- J2710 — Injection, neostigmine methylsulfate, up to 0.5 mg
- J2711 — Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- J2720 — Injection, protamine sulfate, per 10 mg
- J2724 — Injection, protein c concentrate, intravenous, human, 10 iu
- J2725 — Injection, protirelin, per 250 mcg
- J2730 — Injection, pralidoxime chloride, up to 1 gm
- J2760 — Injection, phentolamine mesylate, up to 5 mg
- J2765 — Injection, metoclopramide hcl, up to 10 mg
- J2770 — Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777 — Injection, faricimab-svoa, 0.1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2785
- Watch J2785 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2785
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.